共 683 条
[91]
Hansson GC(2020)The impact of purinergic system enzymes on noncommunicable, neurological, and degenerative diseases Molecules 25 1-212
[92]
König P(2006)1α, 25-Dihydroxyvitamin D3 alters ectonucleotidase expression and activity in human cutaneous melanoma cells Pharmacol Ther 112 719-317
[93]
Soo N(2004)Purinergic receptors in neurological diseases with motor symptoms: targets for therapy J Biol Chem 279 20234-14
[94]
Ermund A(2009)Purinergic system in psychiatric diseases Pflug Arch Eur J Physiol 457 1373-11
[95]
Pieper M(2013)The therapeutic potential of purinergic signalling Purinergic Signal 9 285-8
[96]
Gianotti A(2010)Potential therapeutic role of purinergic receptors in cardiovascular disease mediated by SARS-CoV-2 Sci Signal 3 1-607
[97]
Capurro V(2017)Stimulation of chloride secretion by P1 purinoceptor agonists in cystic fibrosis phenotype airway epithelial cell line CFPEo- Biomed J 40 245-8
[98]
Delpiano L(2011)TRPV4 and purinergic receptor signalling pathways are separately linked in airway epithelia to CFTR and TMEM16A chloride channels Nat Rev Immunol 11 201-15
[99]
Mielczarek M(2014)Purine and pyrimidine receptors Nature 509 310-235
[100]
García-Valverde M(2016)CD39 and CD73 in immunity and inflammation Front Physiol 7 1-61